Mortality and morbidity risk prediction for older former smokers based on a score of smoking history

• Verfasst von: Gao, Xu [VerfasserIn]
• Verfasst von: Huang, Ninghao [VerfasserIn]
• Verfasst von: Jiang, Meijie [VerfasserIn]
• Verfasst von: Holleczek, Bernd [VerfasserIn]
• Verfasst von: Schöttker, Ben [VerfasserIn]
• Verfasst von: Huang, Tao [VerfasserIn]
• Verfasst von: Brenner, Hermann [VerfasserIn]
• Titel: Mortality and morbidity risk prediction for older former smokers based on a score of smoking history
• Titelzusatz: evidence from UK Biobank and ESTHER cohorts
• Verf.angabe: Xu Gao, Ninghao Huang, Meijie Jiang, Bernd Holleczek, Ben Schöttker, Tao Huang, Hermann Brenner
• E-Jahr: 2022
• Jahr: 01 July 2022
• Umfang: 10 S.
• Fussnoten: Gesehen am 29.07.2022
• Titel Quelle: Enthalten in: Age & ageing
• Ort Quelle: Oxford : Oxford Univ. Press, 1972
• Jahr Quelle: 2022
• Band/Heft Quelle: 51(2022), 7, Artikel-ID afac154, Seite 1-10
• ISSN Quelle: 1468-2834
• DOI: doi:10.1093/ageing/afac154
• Datenträger: Online-Ressource
• Sprache: eng
• K10plus-PPN: 1811991963

Abstract

Rapid population ageing has raised the proportion of older former smokers considerably, but a comprehensive assessment tool of former smoking-related health risks is absent.We utilised the large-scale data of UK Biobank and ESTHER study to build a former smoking score (FSS) for older former smokers using three major former smoking traits: pack-years, smoking duration and time since smoking cessation.UK Biobank and ESTHER study are two cohorts of older adults with 502,528 and 9,940 participants from the UK and Germany, respectively.Smoking history and covariates were retrieved from the self-administrated questionnaires and mortality and morbidity data were obtained through regular linkages to hospital records.We constructed the FSS based on the 94,446 former smokers of UK Biobank by retrieving the averaged effect estimates of each trait with a 100-time random sampling. This score was robustly associated with higher risks of mortality and incidence of major smoking-related diseases, outperforming each trait. In the validation panel of 2,683 former smokers from ESTHER study, the FSS was highly predictive of mortality and morbidities. Particularly, compared with the 1st quartile of the FSS group, the 4th quartile group had 114.1, 104.5 and 158.9% higher risks of all-cause, CVD and cancer mortality, respectively, and 41.9, 31.9, 52.4 and 831.3% higher risks of incident CVD, type 2 diabetes, any cancers and lung cancer, respectively.Our study demonstrates the large potential of refined risk assessment of former smokers by more comprehensive consideration of the major traits of former smoking.